Amino aldehyde intermediates exhibit extreme chemical lability, undergoing nonproductive cyclization and polymerization in bulk solvent at rates orders of magnitude faster than enzymatic recapture. This kinetic mismatch has posed a fundamental bottleneck for transaminase-mediated stepwise diamination. Here, we resolve this long-standing challenge by discovering a previously unrecognized trans-subunit tunnel within a homodimeric transaminase that directly channels the unstable amino aldehyde intermediate between the two pyridoxal-5′-phosphate (PLP) active sites, bypassing release and rebinding. Mechanism-guided semi-rational engineering of the trans-subunit tunnel in Shimia marina transaminase (SMTA) yielded the S122G/Y324N with 1.98-fold enhanced catalytic efficiency (kcat/KM) for the stepwise diamination of 2,5-diformylfuran (DFF) to bis(aminomethyl)furan (BAMF). Stopped-flow kinetics and molecular dynamics simulations revealed that the mutations shift the tunnel from a tight-binding locked state to a dynamic-transport regime, reducing steric hindrance and optimizing electrostatic guidance to accelerate inter-subunit intermediate transit. A whole-cell cascade converting renewable 5-hydroxymethylfurfural (5-HMF) to BAMF—a promising bio-based diamine for advanced polyamides—was subjected to techno-economic (TEA) and life cycle (LCA) analyses. Together, these findings establish tunnel engineering as a generalizable paradigm for sequential biocatalytic amination. This work provides a mechanism-driven blueprint for efficient transaminase-mediated stepwise diamination, enabling biocatalytic production of bio-based diamines from renewable feedstocks.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: